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Abstract
Fluorescence in the near-infrared (NIR) spectral region is suitable for in vivo imaging due to its reduced background and
high penetration capability compared to visible fluorescence. SNAPf is a fast-labeling variant of SNAP-tag that reacts with a
fluorescent dye-conjugated benzylguanine (BG) substrate, leading to covalent attachment of the fluorescent dye to the
SNAPf. This property makes SNAPf a valuable tool for fluorescence imaging. The NIR fluorescent substrate BG-800, a
conjugate between BG and IRDye 800CW, was synthesized and characterized in this study. HEK293, MDA-MB-231 and SK-
OV-3 cells stably expressing SNAPf-Beta-2 adrenergic receptor (SNAPf-ADRb2) fusion protein were created. The ADRb2
portion of the protein directs the localization of the protein to the cell membrane. The expression of SNAPf-ADRb2 in the
stable cell lines was confirmed by the reaction between BG-800 substrate and cell lysates. Microscopic examination
confirmed that SNAPf-ADRb2 was localized on the cell membrane. The signal intensity of the labeled cells was dependent
on the BG-800 concentration. In vivo imaging study showed that BG-800 could be used to visualize xenograph tumors
expressing SNAPf-ADRb2. However, the background signal was relatively high, which may be a reflection of non-specific
accumulation of BG-800 in the skin. To address the background issue, quenched substrates that only fluoresce upon
reaction with SNAP-tag were synthesized and characterized. Although the fluorescence was successfully quenched, in vivo
imaging with the quenched substrate CBG-800-PEG-QC1 failed to visualize the SNAPf-ADRb2 expressing tumor, possibly due
to the reduced reaction rate. Further improvement is needed to apply this system for in vivo imaging.
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Introduction
Fluorescence has been extensively used in biological research to
visualize molecular and cellular events. Its application ranges from
visualizing targeting molecules in single cells to imaging physio-
logical and pathological alterations in whole animals [1,2]. Its high
sensitivity and stability, and simplicity of multiplexing offer
advantages over other imaging methods in many applications.
The most commonly used fluorophores include organic dyes,
fluorescent proteins and quantum dots [1]. Each class of
fluorophores has its own advantages and limitations. For example,
fluorescent proteins can be easily expressed in cells and whole
organisms. On the other hand, fluorescent organic dyes are more
suitable for conjugation to other molecules, such as nucleic acids
and proteins.
It is of great interest to develop fluorophores with excitation (Ex)
and emission (Em) maxima in the near-infrared (NIR) region
(700–900 nm). With fluorescence in the NIR region, cells, buffers
and plastic materials used in assays have reduced background. As a
result, NIR fluorescence imaging offers higher sensitivity and
better signal-to-background (S/B) ratio compared to visible
spectra. More importantly, due to the reduced light absorption
and scattering of NIR light in animal tissues, and the low tissue
autofluorescence in the NIR region, NIR fluorescence is well-
suited for in vivo animal imaging [2,3,4]. Significant efforts have
been made to shift the spectra of the fluorescent proteins to longer
wavelengths [5,6,7,8]. The most red-shifted fluorescent proteins
are bacteriophytochrome-based near-infrared fluorescent proteins
IFP1.4 [8] and iRFP [9]. However, the Ex/Em peaks of IFP1.4
(Ex/Em: 684/708 nm) and iRFP (Ex/Em: 690/713 nm) are still
significantly lower compared to those of NIR fluorescent dyes such
as IRDye 800CW (Ex/Em: 774/789 nm).
SNAPf is a fast-labeling variant of SNAP-tag, which is derived
from the human DNA repair protein O
6-alkylguanine-DNA-
alkyltransferase (AGT) [10]. It reacts specifically and rapidly with
benzylguanine (BG) derivatives, leading to covalent labeling of the
SNAPf with a variety of functional moieties, such as fluorescent
dyes, biotin and solid surfaces. The fusion of SNAPf to a protein of
interest yields a tagged protein capable of forming a covalent
linkage to fluorescent dyes [11,12].
The NIR fluorescent dye IRDye 800CW has been conjugated
to a variety of molecules for different applications. Examples
include labeled antibodies for Western, In-Cell-Western, and
labeled 2-deoxyglucose, RGD peptide and target-specific peptides
for animal imaging [13,14,15]. An epidermal growth factor
receptor (EGFR)-specific Affibody molecule labeled with IRDye
800CW has been successfully used in cell-based plate assays,
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studies [15]. Recently, a toxicity study on IRDye 800CW revealed
that there was no observed adverse effect at a dose of
approximately 10,000 times higher than the projected dose for
in vivo imaging. This is the first toxicity study on a NIR dye with
the functional labeling potential [16].
In this study, the BG-800 substrate was synthesized by a one-
step reaction between IRDye 800CW-NHS ester and BG-NH2.
BG-800 was characterized using both cell-based assay and in vivo
imaging. To reduce the background, quenched substrates
containing IRDye 800CW and IRDye QC1 conjugated at the
benzyl and guanine groups of BG, respectively, were created and
characterized.
Materials and Methods
Ethics statement
All experimental procedures for the use of animals were
previously reviewed and approved by the institutional animal
care and use committee (IACUC) at the University of Nebraska-
Lincoln (protocol #402), and all of the experiments were
conducted in accordance with the Guide for the Care and Use
of Laboratory Animals published by the US National Institutes of
Health.
Chemicals and reagents
The SNAPf-Beta-2 adrenergic receptor (SNAPf-ADRb2) vector,
amine-terminated building block BG-NH2, BG-782 (SNAP-
Surface 782) and purified SNAPf-EGF protein were from New
England Biolabs (Ipswich, MA). The IRDye 800CW and IRDye
QC1 were from LI-COR Biosciences (Lincoln, NE). The synthesis
of BG substrates (BG-800, CBG-800-QC1 and CBG-800-PEG-
QC1) was conducted at New England Biolabs based on previously
published methods [10]. The structures of these substrates are
shown in Fig. S1. All substrates were reconstituted in DMSO to
1 mM as stock solutions. TO-PRO-3 and DAPI nucleus staining
reagents were purchased from Invitrogen (Carlsbad, CA).
Cell culture
The human ovarian adenocarcinoma cell line SK-OV-3, breast
adenocarcinoma cell line MDA-MB-231 and embryonic kidney
293 (HEK293) cells were obtained from the American Type
Culture Collection (ATCC, Manassas, VA). HEK293 and MDA-
MB-231 cells were maintained in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10% fetal calf serum (FBS)
and 1% penicillin-streptomycin (complete DMEM). SK-OV-3
cells were maintained in McCoy’s 5 A medium (McCoy)
supplemented with 10% fetal calf serum (FBS) and 1%
penicillin-streptomycin (complete McCoy).
To collect cell lysates, cells were rinsed with PBS once before
adding RIPA buffer. The cells were then incubated on ice in RIPA
buffer for 15 min. The cell lysates were collected and centrifuged
at 4uC to separate the supernatant from the cell debris.
Cell transfection and stable cell line generation
The cell transfection procedure was modified from the
previously described method [17]. Lipofectamine 2000 (Invitro-
gen, Carlsbad, CA) was used to deliver the SNAPf-ADRb2
plasmid into the cells. Two days after transfection the cells could
be used for in vitro imaging studies as described below. For stable
cell selection, the culture medium was replaced with that contains
G418 at 24 h after transfection. The G418 resistant cells were
pooled and stored for future use.
Reaction of BG substrates with cell lysate
BG substrates were added to cell lysate (1 mg/ml) to a final
concentration of 500 nM. The reaction was conducted at room
temperature. The reaction mixtures were resolved by gel
electrophoresis. The labeled protein bands were visualized by
scanning the gel on an Odyssey Infrared Imaging System (LI-
COR Biosciences).
Cell staining with BG substrates in 96-well plates
Cells were seeded at approximately 3610
4 (MDA-MB-231),
2610
4 (HEK293) or 1610
4 (SK-OV-3) cells per well in 96-well
plates and cultured overnight before the assay. The cell density
was about 80–90% confluent at the time of assay. The BG
substrates were diluted in complete cell culture medium to
designated concentrations and incubated in the 37uC5 %C O 2
incubator for 30 min except where otherwise stated. Cells were
fixed with 3.7% formaldehyde/PBS and washed with PBS
containing 0.1% Tween 20 (PBST), and then incubated in TO-
PRO-3 nucleus stain agent (1:5000 in PBS) to normalize for cell
numbers. After three additional washes with PBST, the plates
were scanned and signal intensity quantified [18].
Microscopic analysis
Cells were seeded in 6-well plate with cover slips and cultured
overnight. The cells were incubated with 1 mM BG substrates at
37uC5 %C O 2 for 30 min, fixed, permeabilized and washed as
described above. Instead of TO-PRO-3, DAPI nucleus staining
agent was used to visualize the nuclei by microscopy. After the
final wash, the cover slips were mounted on glass slides with
Fluoromount reagent (Sigma, St. Louis, MO). The images were
acquired using an Olympus IX81 Inverted microscope system
equipped with a halogen bulb (Olympus, Hamburg, Germany).
NIR filters (EX: 710/75 nm, EM: 810/90 nm; Chroma Tech-
nology Corp., Rockingham, VT) were used for IRDye 800CW
detection. The images were deconvolved using the accompanying
software.
Xenograft mouse model
Mice were maintained on a purified maintenance diet (AIN-
93M) from Harlan Teklad (Madison, WI). The xenograft tumors
were established as previously described with modifications [19].
In brief, athymic nude (nu/nu) mice, obtained from Charles River
Laboratories, Inc. (Cambridge, MA) at 4 weeks of age, were
subcutaneously injected with 5610
6 SK-OV-3 cell suspension in
0.1 ml serum-free media. Imaging studies began when tumors
reached about 5 mm in size.
In vivo animal imaging
Mice were anesthetized with 2% isoflurane throughout the
procedures. For imaging experiments, the BG substrates were
diluted in 100 ml PBS and injected through the tail vein. The
images were acquired at indicated time points with a Pearl
Impulse Imager (LI-COR Biosciences). The Ex/Em settings for
the 700 nm channel and 800 nm channel were 685/720 nm and
785/820 nm, respectively. The images were analyzed using the
accompanying software [14].
Organ and tissue analysis
Mice were sacrificed at 1 d after BG substrates injection, and
dissected to collect the organs. The excised organs were rinsed in
PBS, and imaged using a Pearl Impulse Imager. For gel analysis,
tissue samples were homogenized in RIPA buffer. After centrifu-
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analyzed by in-gel fluorescence scanning.
Results
BG-800 labeling of cells transiently transfected with
SNAPf-ADRb2
A SNAPf-ADRb2 expressing plasmid was used in this study.
The ADRb2 portion of the fusion protein directs the localization
of the protein to the cell membrane. HEK293 cells were
transiently transfected with SNAPf-ADRb2 using a Lipofectamine
2000-mediated method. After 2 d culture, the transfected cells
were labeled with BG-800. Because the labeling is irreversible,
excess substrate could be washed away [12]. The fluorescence
signal on SNAPf-ADRb2 transfected cells was about 24 times
higher than that of un-transfected HEK293 cells (Fig. 1),
indicating that the BG-800 substrate could react with SNAPf-
ADRb2 protein. Microscopic examination revealed that the
fluorescence signal was mainly on the cell membrane (Fig. 1, inset).
Generation of stable cells expressing SNAPf-ADRb2 and
labeling with BG-800
HEK293, MDA-MB-231 and SK-OV-3 cells stably expressing
SNAPf-ADRb2 were selected using G418-containing medium.
These cells were designated as 293-SNAPf, MDA-SNAPf and
SKOV-SNAPf, respectively. The expression of SNAPf-ADRb2i n
the stable cells was determined by the reaction between BG-800
and cell lysates. Fig. 2A shows a representative gel image in which
the reaction mixtures were resolved. Each of the three stable cell
lines showed a positive band, presumably resulting from the
reaction between SNAPf-ADRb2 and BG-800. As a comparison,
this band was absent for parental cell lines. The calculated
molecular weight of SNAPf-ADRb2 is about 70-kDa, which
matches the molecular weight of the bands on the gel.
Microscopic examination also confirmed the SNAPf-ADRb2
expression in the stable cells. It also demonstrated that the
fluorescence signal was predominantly on the cell membrane
(Fig. 2B), indicating the correct localization of SNAPf-ADRb2
protein. However, signals were also observed inside the cells,
probably representing internalized SNAPf-ADRb2 after labeling.
The reaction signal is dependent on BG-800
concentration
The reaction signals between BG-800 and SNAPf-ADRb2
stable cells were dependent on BG-800 concentration. With the
increase of BG-800 concentration, the signal intensity also
increased (Fig. 3). All three cell lines showed a similar trend, and
the maximum signals were reached when approximately 200 nM
Figure 1. Reaction of BG-800 with HEK293 cells expressing
SNAPf-ADRb2 protein. HEK293 was transiently transfected with
SNAPf-ADRb2 expression plasmid. After 2 d of culture, cells were
reacted with BG-800. The fluorescence signal on the cells was measured
by scanning on Odyssey Infrared Imaging System. HEK293 cells
transfected with empty vector were used as a control. Shown in the
inset is a representative microscopic image of BG-800 stained HEK293
cells expressing SNAPf-ADRb2.
doi:10.1371/journal.pone.0034003.g001
Figure 2. Confirmation of SNAPf-ADRb2 stable cell lines. (A)
HEK293, MDA-MB-231, and SK-OV-3 cells stably expressing SNAPf-
ADRb2 (designated as 293-SNAPf,M D A - S N A P f and SKOV-SNAPf,
respectively) were lysed in RIPA buffer. The cell lysates were reacted
with BG-800 substrate and run on a SDS-PAGE gel. The 70-kDa bands
represented the SNAPf-ADRb2 protein. The parental cell lines of the
stable cells were used as negative controls. 1, HEK293; 2, 293-SNAPf;3 ,
MDA-MB-231; 4, MDA-SNAPf; 5, SK-OV-3; 6, SKOV-SNAPf. (B) Microscopic
examination of BG-800 reaction with stable cell lines expressing SNAPf-
ADRb2. 293-SNAPf, MDA-SNAPf and SKOV-SNAPf cells were incubated
with BG-800 in complete culture medium. The cells were then fixed and
stained with DAPI to show the nuclei. The parental cells of each cell
lines were used as negative controls. Note that BG-800 reaction signals
were mainly on the cell membrane. Scale bar: 10 mm.
doi:10.1371/journal.pone.0034003.g002
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reacted with the same concentrations of BG-800, and minimal
signals were observed (Fig. 3A–C, and inset), lending additional
support that the signal from stable cells is specific.
The combination of BG-800 with SNAPf-ADRb2 offers
better signal to background ratio than other systems
To compare BG-800 with the commercially available SNAP-tag
substrate BG-782, 293-SNAPf and its parental cell line HEK293
were labeled with either BG-800 or BG-782. The signal intensity
of BG-800 reaction with 293-SNAPf was approximately five-fold
higher than that of BG-782 (data not shown). The ratio of 293-
SNAPf signal to HEK293 signal is defined as the signal-to-
background (S/B) ratio. The S/B ratio of BG-800 (S/B=29) was
about two-fold higher than that of BG-782 (S/B=14) (Fig. 4). We
also generated HEK293 cells stably expressing the NIR fluorescent
protein IFP1.4 [8]. The resulting stable cell line 293-IFP was also
compared with 293-SNAPf/BG-800. The ratio of 293-IFP signal
to HEK293 signal after biliverdin treatment was 2.1, which is
about 14 times lower than that of 293-SNAPf/BG-800.
Tumors expressing SNAPf-ADRb2 can be visualized by
BG-800
The BG-800 substrate was evaluated in vivo in mouse models.
Nude mice bearing SKOV-SNAPf tumors (Tm-S) on one side and
SK-OV-3 tumors (Tm-C) on the other side were injected with
10 nmol of BG-800 through the tail vein. Whole mouse images
were acquired at 24 h after imaging agent administration. Fig. 5A
showed that SNAPf-ADRb2 expressing tumor could be visualized
by BG-800 at 24 h post injection. The higher fluorescence signal
in Tm-S was revealed more clearly by ex vivo imaging after tissue
dissection (Fig. 5A, inset). The ratios of Tm-S/Tm-C and Tm-S/
Figure 3. Concentration dependent reaction of BG-800 with stable cells. 293-SNAPf (A), MDA-SNAPf (B) and SKOV-SNAPf (C) stable cells were
reacted with different concentrations of BG-800. The fluorescence signals from the reaction were scanned on Odyssey Infrared Imaging System and
quantified. TO-PRO-3 staining was used as the internal control. The insets represent scanned images of BG-800 (100 nM) stained stable cells (SNAPf)
and control cells (Ctrl). RFU, relative fluorescence unit.
doi:10.1371/journal.pone.0034003.g003
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was noticed that the background fluorescence signal was high.
This high background signal might be caused by accumulation of
BG-800 in the skin, as demonstrated by ex vivo imaging analysis
(Fig. 5B). Other organs with high BG-800 accumulation included
kidney, liver and lung.
To assess whether the tumor signal was from the specific
labeling of SNAPf-ADRb2 by BG-800, the tumor lysate was
analyzed by gel electrophoresis. Fig. 5C showed that Tm-S
lysate contained a product with the same size as the product
from the reaction between BG-800 and SKOV-SNAPf cell
lysate. In comparison, neither muscle nor SK-OV-3 tumor (Tm-
C) contained this product. This product was also absent from
other tissue lysates, including liver, lung and kidney (data not
shown).
Quenched BG substrates
To assess whether the non-specific background signal could be
reduced by using quenched substrates, CBG-800-QC1 was
synthesized by conjugating IRDye 800CW and IRDye QC1to
the benzyl and guanine groups, respectively. To decrease the
adverse steric effect of the bulky IRDye QC1, a PEG linker was
incorporated between IRDye QC1 and guanine. This version of
quenched substrate with a PEG linker was designated as CBG-
800-PEG-QC1 (Fig. S1). The quenching efficiencies of CBG-800-
QC1 and CBG-800-PEG-QC1 were estimated to be 97% and
94%, respectively.
When incubated with excess purified SNAPf-EGF protein, the
reaction signal from CBG-800-PEG-QC1 increased over time,
and approached the level of BG-800 after 6 h (Note that
unreacted BG-800 was not separated from the reaction mixture).
In contrast the reaction signal from CBG-800-QC1 was only
21% of that of BG-800 after the same period of reaction (Fig. 6A).
Analysis by gel electrophoresis demonstrated that although the
intensities varied, the molecular weights of the reaction products
from all BG substrates were the same (Fig. 6B). Reaction with
SNAPf-ADRb2 expressing cells revealed that CBG-800-PEG-
QC1 produced stronger signal than CBG-800-QC1. However
signals from both CBG-800-PEG-QC1 and CBG-800-QC1 were
much weaker compared to that of BG-800 (data not shown),
indicating that a quencher on the guanine adversely affected the
reactivity.
As the reaction performance of CBG-800-PEG-QC1 was
superior compared to BG-800- QC1, CBG-800-PEG-QC1 was
used for in vivo animal imaging tests. Minimal background signal
was observed for the quenched substrate even at the early stage
post probe injection when the clearance had not occurred (Fig.
S2), indicating that the quenching effect of the probe persevered in
vivo. However, CBG-800-PEG-QC1 failed to detect the SNAPf-
ADRb2 expressing tumors under these conditions.
Figure 4. Comparison of signal to background (S/B) ratios of
different systems. HEK293 cells expressing either SNAPf-ADRb2o r
IFP1.4 were used. Both SNAPf-ADRb2 and IFP1.4 are under the control
of the CMV promoter. SNAPf-ADRb2 expressing cells (293-SNAPf) were
stained with BG-800 (SNAPf/BG-800) or BG-782 (SNAPf-BG-782),
respectively. IFP1.4 expressing cells were incubated with biliverdin
(IFP/BV). The excess substrate and biliverdin were washed away after
reaction. The fluorescence signals of the cells were scanned on the
culture plate without trypsinization and concentration. Signals were
detected at their respective optimal wavelength (Ex/Em: 785/820 nm
for BG-800 and BG-782; 685/720 nm for IFP1.4). The signals of HEK293
parental cells stained with the respective substrates or biliverdin were
defined as background.
doi:10.1371/journal.pone.0034003.g004
Figure 5. In vivo imaging with BG-800 substrate. (A) Xenograft
tumors were established using either SK-OV-3 parental cells as the
control (Tm-C, left side) or SKOV-SNAPf stable cells (Tm-S, right side).
The mice were imaged 24 h after i.v. injection of 10 nmol of BG-800
substrate. The tumors were indicated with arrows. The tumors were
dissected and imaged ex vivo after whole animal imaging (lower left
corner inset). (B) Tissue distribution of BG-800. Tissues were dissected
24 h after BG-800 administration and imaged. Note that the tissues
were from a different mouse as shown in (A). Ht, Heart; Int, intestine; Kd,
kidney; Lg, lung; Lv, liver; Ms, muscle; Sk, skin; Spl, spleen; Tm-C, SK-OV-
3 tumor; Tm-S, SKOV-SNAPf tumor. (C) Gel analysis of tissue lysates from
Ms, Tm-C, Tm-S and SKOV-SNAPf cell lysate reacted with BG-800 (Cell-S).
doi:10.1371/journal.pone.0034003.g005
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Fluorescence technology has become an indispensable tool for
biological and biomedical research. SNAP-tag fluorescence
imaging has been used in various applications, including protein-
protein interaction [20], hydrogen peroxide detection [21],
monitoring zinc flux [22], virus-cell interactions [23] and super-
resolution imaging of live cells [24]. SNAPf used in this study is a
fast-labeling variant of SNAP-tag with some extra mutations [10].
As a new technology discovered less than a decade ago [12], the
SNAP-tag has some advantages over fluorescent proteins. Firstly,
NIR SNAP-tag substrates could be synthesized readily from NIR
dyes. As a result, NIR fluorescence imaging is greatly facilitated
with SNAP-tag. This is in contrast to the efforts needed to
engineer NIR fluorescent proteins. Secondly, a variety of
fluorescent substrates with different colors could be used to label
one single SNAP-tag without a requirement for separate cloning
and expression for each color. Once a stable cell line or transgenic
animal is established, the color on the SNAP-tag can be easily
altered by using a substrate with different Ex/Em spectra.
However, changing to a different color with fluorescent proteins
entails laborious processes of re-establishing stable cell lines or
transgenic animals de novo. Thirdly, the labeling time with SNAP-
tag can be controlled easily, allowing for ‘‘pulse-chase’’ experi-
ments that require labeling with different probes at different time
points.
Although SNAP-tag technology has been widely used in cell
imaging, much less work has been done to apply this technology in
animal imaging. A fusion protein of SNAP-tag with a single-chain
antibody fragment has enabled targeting EGFR-overexpressing
tumors. However, the labeling of SNAP-tag by NIR substrates was
conducted in vitro in that study [25]. In a recent report, BG-782
was successfully used to label SNAP-tag in vivo. Tumors expressing
SNAP-tag fusion proteins were visualized and the half-lives of
SNAP-tag fusion proteins were measured in vivo [26].
A NIR fluorescent SNAP-tag substrate BG-800 was synthesized
by conjugating IRDye 800CW to BG-NH2. Because BG-800 is
cell impermeable, we choose to use the SNAPf-ADRb2 fusion
protein, in which ADRb2 directs the localization of SNAPf fusion
protein to the cell membrane. BG-800 reacted with SNAPf-
ADRb2 in both cell lysate and live cell culture. It was also found
that BG-800 produced a higher signal and S/B ratio compared to
BG-782 in cell-based assay. The tumors expressing SNAPf-
ADRb2 could be visualized by BG-800. The signal was from
the specific reaction between SNAPf-ADRb2 and BG-800, as
evidenced by gel analysis of protein exacts from the dissected
tumors. However the relatively high signal in the skin, presumably
due to the non-specific accumulation of BG-800 in this tissue,
produced high background. The accumulation of BG-800 in the
skin is unlikely caused by IRDye 800CW because little skin signal
has been detected with either free dye or various other IRDye
800CW conjugates, including small organic molecules (such as 2-
DG), small peptides (such as RGD), large peptides (such as EGF,
Affibody) and antibodies [14,15,27,28]. It is also noteworthy that a
HaloTag probe containing IRDye 800CW was used to detect
HaloTag expressing tumors. No skin accumulation problem was
noted in that study [29].
One possible solution to the background issue is to use
quenched substrates, which only fluoresce upon reaction with
SNAP-tag. The quenched substrates are desirable in cell-based
assay because they could eliminate the wash step which is needed
for the conventional unquenched substrates [10,30]. More
importantly, the quenched substrate will produce minimal
background when used in animal imaging, where the clearance
of the substrate from the body is more difficult and much slower
compared to the cell culture system. Various quenching
mechanisms, such as self-quenching, Fo ¨rster resonance energy
transfer (FRET), H-dimer formation and photon-induced electron
transfer (PeT), have been employed in fluorescence imaging
[31,32]. As guanine is known to quench the fluorescence of certain
dyes by PeT, various dyes were tested for their quenching
efficiency by guanine after conjugation to BG. Several BG
substrates were discovered to have a strong (.10-fold) increase
in their fluorescence upon covalent labeling of the SNAP-tag [33].
A more general method is based on the FRET principle. A
fluorescent dye and a quencher could be linked to the benzyl
moiety and the guanine moiety, respectively. In this substrate, the
fluorescence of the dye is quenched by the closely-linked quencher.
After reaction with SNAP-tag, the guanine-quencher group will
separate from the benzyl-dye group, resulting in the restoration of
the fluorescence. The quencher was linked to the C-8 or N-9
positions, and the resulting substrates were characterized.
Although the substrates were quenched in both situations, the
C-8 modification exhibited better reaction kinetics [30,34]. A
variety of quenched substrates with different combinations of
fluorescent dyes and quenchers linked at C-8 position have been
synthesized and tested [10]. However, none of these quenched
substrates has Ex/Em spectra in the NIR region.
We synthesized the NIR quenched substrate CBG-800-QC1 by
conjugating IRDye 800CW and IRDye QC1 at the benzyl group
and C-8 position of guanine group, respectively. The reaction
speed of this substrate was greatly reduced compared to the
unquenched BG-800. This is not surprising given that C-8
Figure 6. Reaction of BG-800, CBG-800-QC1 and CBG-800-PEG-
QC1 substrates with purified SNAPf-EGF protein. (A) BG
substrates (100 nM) were incubated with SNAPf-EGF protein (15 ng/
ml) in a 96-well plate. The plate was scanned after different time periods
of reaction to measure the fluorescence signal. (B) The reaction
mixtures of SNAPf-EGF with different BG substrates were resolved on a
SDS-PAGE gel and scanned to visualize the labeled protein.
doi:10.1371/journal.pone.0034003.g006
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of the substrate [30]. It has also been reported that different
quenchers affect the binding and conjugation of the substrate to
the SNAPf differently [10]. IRDye QC1 (MW 1244) is a relatively
large molecule [35], and may hinder the access of the substrate to
the active site of the enzyme. A PEG linker between IRDye QC1
and guanine improved the reaction rate, possibly by alleviating the
hindrance effect of IRDye QC1. However this PEG containing
quenched substrate CBG-800-PEG-QC1 failed to visualize the
SNAPf-ADRb2 expressing tumors. Higher doses up to three times
of that used for BG-800 were tried without any significant
improvement (Gong et al., unpublished data). These results
indicate that the reaction rate of CBG-800-PEG-QC1 is not fast
enough to match the quick body clearance of the substrate in the
system we used. Although it is possible that CBG-800-PEG-QC1
may be used to visualize tumors established from other cell lines
with higher SNAPf-ADRb2 expression levels, or tumors expressing
different SNAP-tag fusion proteins, our results suggest that
improvement is needed to make this system suitable for general
imaging applications. Several strategies could be envisioned to
achieve this goal. Firstly, it might be beneficial to replace the bulky
QC1 by smaller quenchers such as BHQ-3, which could also
quench emission of NIR fluorescent dyes [36]. Secondly, a SNAP-
tag mutant could be selected specifically for the quenched
substrates. Thirdly, a quenched substrate with a longer circulation
time in vivo could also improve the performance.
Fluorescence optical imaging has the advantage of multiple
channels, which can be employed to image two or more targets
simultaneously [37,38]. A second version of AGT-based tag
named CLIP-tag, which reacts specifically with benzylcytosine
(BC) derivatives, has also been developed [39]. Because SNAP-tag
and CLIP-tag only react with their specific substrates, they could
be used simultaneously for dual-color fluorescence imaging. The
SNAP-tag can also be combined with other protein-tags, such as
HaloTag [29], or other reporter gene systems that use fluorescent
substrates, such as b-galactosidase/DDAOG system [40], to create
multiplexed imaging systems.
Supporting Information
Figure S1 Structures of BG substrates. (A) BG-800. (B)
CBG-800-QC1. (C) CBG-800-PEG-QC1.
(TIF)
Figure S2 Comparison of BG-800 and CBG-800-PEG-
QC1 in vivo. Nude mice were injected with 10 nmol BG-800 or
CBG-800-PEG-QC1 and imaged at different time points. Note
that the fluorescence signal of CBG-800-PEG-QC1-injected
mouse was much lower than that of BG-800-injected mouse.
(TIF)
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